SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Oct-24 8:31 AM View: | Aprea Therapeutics, Inc. (APRE) | 15-Oct-24 | Market Purchase | 250 | $2.90 | $725.00 | < 1% 334.44K to 334.69K | (4%) |
15-Oct-24 8:31 AM View: | Aprea Therapeutics, Inc. (APRE) | 14-Oct-24 | Market Purchase | 1,000 | $2.59 | $2,590.00 | < 1% 333.44K to 334.44K | 8% |
15-Oct-24 8:31 AM View: | Aprea Therapeutics, Inc. (APRE) | 10-Oct-24 | Market Purchase | 150 | $2.54 | $381.00 | < 1% 333.3K to 333.44K | 10% |
28-Mar-24 5:57 PM View: | Aprea Therapeutics, Inc. (APRE) | 28-Mar-24 | Grant | 6,725 | -- | -- | 2% 326.57K to 333.3K | |
14-Mar-24 8:51 PM View: | Aprea Therapeutics, Inc. (APRE) | 13-Mar-24 | Purchase | 2,000 | $7.29 | $14,580.00 | < 1% 322.77K to 324.77K | |
13-Mar-23 6:30 PM View: | Aprea Therapeutics, Inc. (APRE) | 09-Mar-23 | Grant | 4,000 | -- | -- | 1% 318.77K to 322.77K | |
13-Mar-23 6:30 PM View: | Aprea Therapeutics, Inc. (APRE) | 23-Aug-22 | Conversion | 6,045,100 | -- | -- | 1830% 330.31K to 6.38M | |
01-Aug-22 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 28-Jul-22 | Grant | 101,300 | -- | -- | 44% 229.01K to 330.31K |